Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 16;14(11):2084.
doi: 10.3390/genes14112084.

Association of a Single Nucleotide Variant in TERT with Airway Disease in Japanese Rheumatoid Arthritis Patients

Affiliations

Association of a Single Nucleotide Variant in TERT with Airway Disease in Japanese Rheumatoid Arthritis Patients

Takashi Higuchi et al. Genes (Basel). .

Abstract

Interstitial lung disease and airway disease (AD) are often complicated with rheumatoid arthritis (RA) and have a poor prognosis. Several studies reported genetic associations with interstitial lung disease in RA. However, few genetic studies have examined the susceptibility to AD in RA patients. Here, we investigated whether single nucleotide variants susceptible to idiopathic pulmonary fibrosis might be associated with interstitial lung disease or AD in Japanese RA patients. Genotyping of rs2736100 [C/A] in TERT and rs1278769 [G/A] in ATP11A was conducted in 98 RA patients with usual interstitial pneumonia, 120 with nonspecific interstitial pneumonia (NSIP), 227 with AD, and 422 without chronic lung disease using TaqMan assays. An association with AD in RA was found for rs2736100 (p = 0.0043, Pc = 0.0129, odds ratio [OR] 1.40, 95% confidence interval [CI] 1.11-1.77). ATP11A rs1278769 was significantly associated with NSIP in older RA patients (>65 years, p = 0.0010, OR 2.15, 95% CI 1.35-3.40). This study first reported an association of rs2736100 with AD in RA patients and ATP11A rs1278769 with NSIP in older RA patients.

Keywords: airway disease; genetic association; nonspecific interstitial pneumonia; rheumatoid arthritis; single nucleotide variant.

PubMed Disclaimer

Conflict of interest statement

Shigeto Tohma received honoraria from AbbVie GK., Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co. Asahi Kasei Pharma Corp., Astellas Pharma Inc., and Pfizer Japan Inc. Hiroshi Furukawa received honoraria from Ayumi Pharmaceutical Corp., Pfizer Japan Inc., Luminex Japan Corp. Ltd., Ajinomoto Co. Inc. Dainippon Sumitomo Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., and Takeda Pharmaceutical Co. Shigeto Tohma was supported by research grants from Abbott Japan Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corp., Merck Sharp and Dohme Inc., Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Pfizer Japan Inc., Teijin Pharma Ltd., and Astellas Pharma Inc. Hiroshi Furukawa was supported by research grants from Japan Research Foundation for Clinical Pharmacology supported by Daiichi Sankyo, Daiwa Securities Health Foundation established by Daiwa Securities Group Inc., Takeda Science Foundation run by Takeda Pharmaceutical Co., Mitsui Sumitomo Insurance Welfare Foundation established by Mitsui Sumitomo Insurance Co., Ltd., Bristol-Myers-Squibb Co., and the Nakatomi Foundation established by Hisamitsu Pharmaceutical Co. Inc. The other authors have no conflict of interest.

Similar articles

  • Association of a FAM13A variant with interstitial lung disease in Japanese rheumatoid arthritis.
    Higuchi T, Oka S, Furukawa H, Shimada K, Tsunoda S, Ito S, Okamoto A, Katayama M, Saisho K, Shinohara S, Matsui T, Migita K, Nagaoka S, Tohma S. Higuchi T, et al. RMD Open. 2023 Jan;9(1):e002828. doi: 10.1136/rmdopen-2022-002828. RMD Open. 2023. PMID: 36717188 Free PMC article.
  • MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P. Juge PA, et al. N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20. N Engl J Med. 2018. PMID: 30345907 Free PMC article.
  • Association of human leukocyte antigen alleles with chronic lung diseases in rheumatoid arthritis.
    Oka S, Furukawa H, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Suda A, Tsunoda S, Ito S, Katayama M, Nakamura T, Saisho K, Sano H, Migita K, Nagaoka S, Tsuchiya N, Tohma S. Oka S, et al. Rheumatology (Oxford). 2016 Jul;55(7):1301-7. doi: 10.1093/rheumatology/kew025. Epub 2016 Apr 5. Rheumatology (Oxford). 2016. PMID: 27048628
  • Recent advances in rheumatoid arthritis-associated interstitial lung disease.
    Juge PA, Crestani B, Dieudé P. Juge PA, et al. Curr Opin Pulm Med. 2020 Sep;26(5):477-486. doi: 10.1097/MCP.0000000000000710. Curr Opin Pulm Med. 2020. PMID: 32701675 Review.
  • [Interstitial lung disease in rheumatoid arthritis].
    Froidevaux-Janin S, Dudler J, Nicod LP, Lazor R. Froidevaux-Janin S, et al. Rev Med Suisse. 2011 Nov 23;7(318):2272-7. Rev Med Suisse. 2011. PMID: 22400361 Review. French.

References

    1. Smolen J.S., Aletaha D., McInnes I.B. Rheumatoid arthritis. Lancet. 2016;388:2023–2038. doi: 10.1016/S0140-6736(16)30173-8. - DOI - PubMed
    1. Stainer A., Tonutti A., De Santis M., Amati F., Ceribelli A., Bongiovanni G., Torrisi C., Iacopino A., Mangiameli G., Aliberti S., et al. Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review. Front. Med. 2023;10:1129939. doi: 10.3389/fmed.2023.1129939. - DOI - PMC - PubMed
    1. Furukawa H., Oka S., Shimada K., Sugii S., Ohashi J., Matsui T., Ikenaka T., Nakayama H., Hashimoto A., Takaoka H., et al. Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: A protective role for shared epitope. PLoS ONE. 2012;7:e33133. doi: 10.1371/journal.pone.0033133. - DOI - PMC - PubMed
    1. Koduri G., Norton S., Young A., Cox N., Davies P., Devlin J., Dixey J., Gough A., Prouse P., Winfield J., et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: Results from an inception cohort. Rheumatology. 2010;49:1483–1489. doi: 10.1093/rheumatology/keq035. - DOI - PubMed
    1. Kim E.J., Elicker B.M., Maldonado F., Webb W.R., Ryu J.H., Van Uden J.H., Lee J.S., King T.E., Jr., Collard H.R. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur. Respir. J. 2010;35:1322–1328. doi: 10.1183/09031936.00092309. - DOI - PubMed

Publication types

LinkOut - more resources